Prevention

A recent landmark decision by the Centers for Medicare and Medicaid Services (CMS) represents an important first step toward addressing one of the great ironies of American health care….

Dinesh Nagi       The prevalence of diabetes is rising rapidly worldwide, and certain developing nations are currently going through an upsurge of type 2 diabetes of epidemic proportions.1

Drugs aimed at halting the molecular destruction of beta cells are likely the next step in the quest to stop the progression of autoimmune type 1 diabetes….

Long-term treatment with metformin is safe for preventing or delaying the development of type 2 diabetes….

For Dr. Kahn’s comments and the Joslin Diabetes Center’s response, see our article in last week’s newsletter: Joslin Replies to Dr. Richard Kahn’s Statement: “Diabetes Prevention is a Waste of Resources.”

Physicians strongly disagree with statements made by former executive of the American Diabetes Association.…

The U.S. Diabetes Prevention Program conducted a clinical trial in 2002 showing that modest weight loss through caloric restriction and increased physical activity reduced the incidence of diabetes in high-risk patients by 58%….

Type 2 diabetes prevention programs aimed at high-risk individuals with a family history of the disease may underuse psychological and motivational strategies that emphasize genetic susceptibility.…

An FDA advisory committee has recommended unanimously that the ezetimibe-simvastatin combination pill (Vytorin) be approved for prevention of cardiovascular disease in CKD patients who are not on dialysis.…

Recent data suggest that treatment with metformin during late childhood or early puberty may impede or prevent the development of polycystic ovary syndrome in girls at high risk for the disease.…